Louise Kooij
Förmögenhet: 79 249 $ per 2026-05-31
Förmögenhet: 79 249 $ per 2026-05-31
Louise Kooij is currently Chief Accounting Officer at NewAmsterdam Pharma Co. NV since 2023.
Formerly, Ms. Kooij was Head-Finance & Operations at Azafaros BV from 2020 to 2023, Head-Rare Disease at Genzyme Therapeutics Ltd. from 2018 to 2020, Product Group Accountant at Hagemeyer NV, and Auditor at PricewaterhouseCoopers BV.
Ms. Kooij graduated from Nyenrode Business Universiteit.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-06-22 | 2 353 ( 0 % ) | 79 249 $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Comptroller/Controller/Revisor | 2023-01-01 |
| Företag | Position | Slut |
|---|---|---|
Azafaros BV
Azafaros BV Pharmaceuticals: MajorHealth Technology Develops therapeutic agents for the treatment of rare metabolic disorders | Finansdirektör/CFO | 2023-03-21 |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for patients affected by rare and debilitating diseases | Företagsledare/Principal | 2020-01-01 |
Hagemeyer NV
Hagemeyer NV Wholesale DistributorsDistribution Services Distributes electrical parts and supplies | Företagsledare/Principal | - |
PricewaterhouseCoopers BV
PricewaterhouseCoopers BV Miscellaneous Commercial ServicesCommercial Services Provides audit, assurance, tax and consulting services | Comptroller/Controller/Revisor | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 6 |
|---|---|
Hagemeyer NV
Hagemeyer NV Wholesale DistributorsDistribution Services Distributes electrical parts and supplies | Distribution Services |
Nyenrode Business Universiteit
Nyenrode Business Universiteit Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for patients affected by rare and debilitating diseases | Health Technology |
PricewaterhouseCoopers BV
PricewaterhouseCoopers BV Miscellaneous Commercial ServicesCommercial Services Provides audit, assurance, tax and consulting services | Commercial Services |
Azafaros BV
Azafaros BV Pharmaceuticals: MajorHealth Technology Develops therapeutic agents for the treatment of rare metabolic disorders | Health Technology |
NewAmsterdam Pharma Co. NV
NewAmsterdam Pharma Co. NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches, develops, manufactures and commercializes transformative therapies for cardio-metabolic diseases | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån